Altanine
San Diego, United States· Est.
Altanine leverages patented enteric coatings to create value‑added oral drug formulations for chronic‑disease markets.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Altanine leverages patented enteric coatings to create value‑added oral drug formulations for chronic‑disease markets.
DiabetesWeight ManagementSexual WellnessNeurocare
Technology Platform
Proprietary enteric coating technology that enables pH‑triggered targeted release of oral drugs, increasing bioavailability and reducing gastrointestinal side effects.
Opportunities
Scaling the enteric coating platform across high‑volume generic markets and licensing the technology to larger pharmaceutical partners.
Risk Factors
Regulatory approval timelines, manufacturing scale‑up challenges, and competition from other drug‑delivery innovators.
Competitive Landscape
Competes with firms offering generic reformulations and enteric‑coating technologies; differentiation stems from proprietary polymer blends and targeted release profiles.